Brendan McLean - Concepedia

Author

Brendan McLean

Also Known As

B McLean, B N McLean, B. McLean, B. N. MCLEAN, B. N. McLean, B.N. McLean, B.N. Mclean, B.N.P. Mclean, Barry McLean, Brendan McLean

Publications

3.9K

Citations

H-Index

108

Concepts

All Affiliations

Royal Cornwall Hospital Cornwall Partnership NHS Foundation Trust University College London Royal Cornwall Hospital Trust National Hospital for Neurology and Neurosurgery

About

Brendan McLean is an author at Royal Cornwall Hospital specializing in medicine, neurology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.2K
2	Education	2	2	30
3	Health Sciences	2	2	76
4	Engineering	1	1	44
5	Nursing	1	1	21

Brendan McLean

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Mutations in the gene encoding peroxisomal α-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy Sacha Ferdinandusse, Peter T. Clayton, J. Rees, Nature Genetics	2000	251
A STUDY OF IMMUNOGLOBULIN G IN THE CEREBROSPINAL FLUID OF 1007 PATIENTS WITH SUSPECTED NEUROLOGICAL DISEASE USING ISOELECTRIC FOCUSING AND THE LOG IgG-INDEX Brendan McLean, Richard Luxton, Edward J. Thompson Brain OphthalmologyNeurophysiologyMedicineCerebrospinal FluidNeurological Disorder	1990	204
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial Anthony G Marson, Girvan Burnside, Richard Appleton, The Lancet	2021	202
Mutations in the gene encoding peroxisomal α-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy Sacha Ferdinandusse, Simone Denis, Peter T. Clayton, Biochemical Society Transactions NeurogenomicsNeurological DisorderGeneticsGenetic EpidemiologyPathology	2001	192
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial Anthony G Marson, Girvan Burnside, Richard Appleton, The Lancet	2021	183
Neuralgic amyotrophy and hepatitis E virus infection J.J.J. van Eijk, R.G. Madden, Annemiek A. van der Eijk, Neurology	2014	180
A study of oligoclonal band negative multiple sclerosis. Adam Zeman, Desmond P. Kidd, Brendan McLean, Journal of Neurology Neurosurgery & Psychiatry	1996	159
Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. Brendan McLean, D. H. Miller, E J Thompson Journal of Neurology Neurosurgery & Psychiatry	1995	155
TROPICAL SPASTIC PARAPARESIS AND HUMAN T CELL LYMPHOTROPIC VIRUS TYPE 1 IN THE UNITED KINGDOM J.K. Cruickshank, Peter Rudge, Angus Dalgleish, Brain Virus EpidemiologyLaboratory ImmunologyViral PathogenesisImmunologyPathology	1989	129
Medical needs of people with intellectual disability require regular reassessment, and the provision of client‐ and carer‐held reports A. Kerr, Daphne L. McCulloch, Karen Anderson Oliver, Journal of Intellectual Disability Research	2003	126

Page 1